US Broker Ratings

SIGA Technologies Inc. (SIGA) Investor Outlook: Unpacking the Valuation Amidst Market Volatility

SIGA Technologies Inc. (NASDAQ: SIGA) is a noteworthy player in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a market capitalization of $478.66 million,..

Neuropace, Inc. (NPCE) Stock Analysis: 88.60% Upside Potential Sparks Investor Interest in Medical Device Innovator

For investors with a keen eye on the healthcare sector, Neuropace, Inc. (NASDAQ: NPCE) stands out as an intriguing prospect. Known for its pioneering work in the medical device industry,..

REGENXBIO Inc. (RGNX) Stock Analysis: Unveiling a 265% Potential Upside in Biotech Innovation

REGENXBIO Inc. (NASDAQ: RGNX) stands as a notable player within the biotechnology sector, a domain known for its dynamic nature and high potential for growth. The company, based in Rockville,..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a 60% Potential Upside for Investors

For those keeping a keen eye on healthcare stocks, Organogenesis Holdings Inc. (NASDAQ: ORGO) presents a compelling investment narrative. With a market capitalization of $553.08 million, this regenerative medicine company..

Castle Biosciences, Inc. (CSTL): Analyst Consensus and Growth Potential Reveal a 106% Upside

Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market cap of $502.09 million, this U.S.-based molecular diagnostics..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 48% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH) stands out in the biotechnology sector, not only for its innovative treatment offerings but also for its intriguing financial prospects. With a market capitalization of..

AxoGen, Inc. (AXGN) Stock Analysis: A 108.82% Upside Potential in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the healthcare sector specializing in medical devices, is capturing investor attention with a compelling potential upside of 108.82%. As a company dedicated..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring the 112.66% Potential Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has captured investor attention with its significant potential upside, as analysts forecast a remarkable 112.66% increase from its current price. Specializing in the development and..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring the Astonishing 5,655% Potential Upside

Cel-Sci Corporation (NYSEAMERICAN: CVM), a clinical-stage biotechnology firm based in Vienna, Virginia, is making waves in the healthcare sector with its innovative approach to cancer treatment and other diseases. The..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Analyzing a 179.83% Potential Upside in Biotech Innovation

Bicara Therapeutics Inc. (NASDAQ: BCAX) is capturing the attention of savvy investors within the biotechnology sector, promising a striking potential upside of 179.83%. As a clinical-stage biopharmaceutical company headquartered in..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 20% Potential Upside in the Telehealth Revolution

LifeMD, Inc. (NASDAQ: LFMD) stands at the confluence of healthcare innovation and digital transformation, offering an intriguing opportunity for investors looking to capitalize on the growth of telemedicine. As a..

COMPASS Pathways Plc (CMPS) Stock Analysis: Unpacking a 309% Potential Upside in Mental Health Innovation

COMPASS Pathways Plc (NASDAQ: CMPS) is garnering attention in the healthcare sector for its pioneering work in mental health treatments. With a current market capitalization of $363.02 million, COMPASS is..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech Play with 71.52% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) has emerged as a noteworthy player within the biotech sector, particularly for investors looking to capitalize on the potential of rare disease treatments. With a..

Claritev Corporation (CTEV) Stock Analysis: Navigating a 22.61% Potential Downside and Strategic Healthcare Innovations

Claritev Corporation (NASDAQ: CTEV) operates in the dynamic healthcare sector, specifically within health information services. Based in New York, Claritev is a pivotal player in providing data analytics and technology-enabled..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A 71% Potential Upside Beckons Savvy Investors

Enliven Therapeutics, Inc. (NASDAQ: ELVN) presents itself as a compelling opportunity in the biotechnology sector, with an impressive potential upside of 71.38%. This clinical-stage biopharmaceutical company, headquartered in Boulder, Colorado,..

EyePoint Pharmaceuticals, Inc. (EYPT) Stock Analysis: Exploring a 207.69% Potential Upside

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is capturing investor attention with its remarkable upside potential, as analysts forecast a possible ascent of over 207.69%. Operating in the dynamic biotechnology sector, EyePoint..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Challenges with a 31% Revenue Growth in a Competitive Market

Sonida Senior Living, Inc. (NYSE: SNDA) operates within the healthcare sector, specializing in medical care facilities, specifically senior housing communities across the United States. As a company that facilitates independent..

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring a Potential 59% Upside in Biotech Innovation

For individual investors seeking opportunities in the dynamic biotech sector, AnaptysBio, Inc. (NASDAQ: ANAB) presents an intriguing case. With a market capitalization of $783.87 million, this San Diego-based clinical-stage biotechnology..

Tilray Brands, Inc. (TLRY) Stock Analysis: Potential Upside of 115.80% Sparks Investor Interest

Tilray Brands, Inc. (NASDAQ: TLRY) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. Headquartered in Leamington, Canada, Tilray..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Analyzing the 101.69% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a prominent name in the biotechnology sector, has caught the attention of investors with a substantial potential upside of 101.69%. Headquartered in San Diego,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds